Inotiv, Inc.·4/A

Jan 12, 4:31 PM ET

Downing Philip A 4/A

4/A · Inotiv, Inc. · Filed Jan 12, 2022

Insider Transaction Report

Form 4/AAmended
Period: 2021-12-22
Downing Philip A
Sen. Dir., Preclinical Srvcs.
Transactions
  • Sale

    Common Shares

    2021-12-22$43.04/sh3,057$131,57740,195 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.115, inclusive, to cover taxes related to the vesting of restricted stock awards. The reporting person undertakes to provide to Inotiv, Inc., any security holder of Inotiv, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    edgar.xml

    FORM 4/A -